Cefuroxime
Active ingredient description
Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Medicines
Cefuroxime is the active ingredient of these drugs:
Hong Kong South Africa
Ireland
Austria Finland France Hong Kong Netherlands
South Africa
Hong Kong
Cyprus Hong Kong Lithuania Singapore
Singapore
South Africa
Poland
Poland
South Africa
Hong Kong
Poland
Ireland
Singapore
South Africa
South Africa
Cyprus Germany
Hong Kong
Hong Kong
Poland South Africa
South Africa
Hong Kong
South Africa
Austria
Italy
Hong Kong
Germany
Hong Kong
Hong Kong Poland
France
Cyprus
Italy
Brazil
South Africa
Brazil
Italy
Spain
Lithuania
Lithuania
Hong Kong
Singapore
Poland
Poland
Italy
Tunisia
Austria Lithuania Netherlands Poland Spain
Hong Kong Lithuania Poland Singapore
Hong Kong
Poland
Spain
Hong Kong
Brazil
Tunisia
Cyprus New Zealand
Brazil Cyprus Finland Hong Kong Ireland
Australia Austria Brazil Cyprus France
Tunisia
Poland
Product monographs
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):
Structural formula
Unique ingredient identifier (UNII)
O1R9FJ93ED - CEFUROXIME
CAS registry number
55268-75-2 - cefuroxime
56238-63-2 - Cefuroxime sodium
64544-07-6 - Cefuroxime axetil
SNOMED-CT
372833007 - Cefuroxime (substance)